Nefazodone-associated torsade de pointes [6]

International Journal of Cardiology

Volumn 93, Issue 1, 2004, Pages 85-86

  Siddiqui, Mumtaz A ^a   Khan, Ijaz A ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Drug induced arrhythmias; Long QT syndrome; Nefazodone; Polymorphic ventricular tachycardia; Torsade de pointes

Indexed keywords

GLIPIZIDE; NEFAZODONE;

ADULT; CASE REPORT; CLINICAL FEATURE; DIAPHORESIS; DIZZINESS; ELECTROCARDIOGRAM; FEMALE; HEART PALPITATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LETTER; PRIORITY JOURNAL; QT INTERVAL; SEIZURE; SINUS RHYTHM; SYNCOPE; THORAX PAIN; TORSADE DES POINTES; VERTIGO;

EID: 0346056796     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-5273(03)00120-7     Document Type: Letter

References (8)

1. DeVane C.L., Grothe D.R., Smith S.L. Pharmacology of antidepressants: focus on nefazodone. J Clin Psychiatry. 63:2002;10-17.
2. Khan I.A. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med. 112:2002;58-66.
3. Khan I.A. Twelve-lead electrocardiogram of torsades de pointes. Tex Heart Inst J. 28:2001;69.
4. Ponti F.D., Poluzzi E., Cavalli A., Recanatini M., Montanaro N. Safety of non-antiarrhythmic drugs that prolong the qt interval or induce torsade de pointes: an overview. Drug Saf. 25:2002;263-286.
5. Singh N., Singh H.K., Singh P.P., Khan I.A. Cocaine-induced torsades de pointes in idiopathic long Q-T syndrome. Am J Ther. 8:2001;299-302.
6. Makkar R.R., Fromm B.S., Steinman R.T., Meissner M.D., Lehmann M.H. Female gender as a risk factor for torsade de pointes associated with cardiovascular drugs. J Am Med Assoc. 270:1993;2590-2597.
7. Greene D.S., Barbhaiya R.H. Clinical pharmacokinetics of nefazodone. Clin Pharmacokinet. 33:1997;260-275.
8. Gitler B., Berger L.S., Buffa S.D. Torsade de pointes induced by erythromycin. Chest. 105:1994;368-372.